Researchers Find A Way To Help People With Meth Addiction Avoid Relapse : NPR

According to older research from 2013, primate models demonstrate that meth alters brain structures involved in inhibitory control. These changes may impede a person’s ability to suppress the urge to engage in behaviors that are counterproductive or harmful. While it is thought semaglutide might help people with PCOS because of its effects on weight loss, experts have suggested other mechanisms could also be at play. The results have led some experts to suggest semaglutide should be routinely prescribed to treat cardiovascular illnesses.

Meth Addiction Treatment: How to Quit Meth

(Some meth addicts are misdiagnosed as having a mental illness such as schizophrenia.) Psychosis can cause extreme paranoia, delusions and hallucinations, including the feeling of one’s skin “crawling” with imaginary parasites. According to the National Institute on Drug Abuse (NIDA), psychosis can last for several months or years after the individual quits using. A combination of two medications, injectable naltrexone and oral bupropion, was safe and effective in treating adults with moderate or severe methamphetamine use disorder in a double-blind, placebo-controlled Phase III clinical trial. The research, published today in The New England Journal of Medicine, was conducted at multiple sites within the National Institute on Drug Abuse Clinical Trials Network (NIDA CTN).

Drugs, Brains, and Behavior: The Science of Addiction

Once the meth cravings fade, the patient can begin to engage in treatment programming. Application of CBT in lesbian, gay, bisexual, transgender and intersex (LGBTI) communitie consistently showed positive results. Thus, CBT either alone or combined with CM reduced METH use, cravings or relapse during treatment in this population [74, 92]. Similarly, CBT diminished relapse and/or cravings in other individuals with METH use disorder e.g. [91, 93-95].

Psychological effects

This is likely because heavy METH use is more damaging to the brain and body than light use of the drug and, therefore, light and heavy METH users respond differently to pharmacotherapies. CM uses motivational incentives and tangible rewards https://ecosoberhouse.com/ to help a person dependent on METH to attain their treatment goals e.g., abstinence from METH. For example, CM participants are provided monetary vouchers in exchange for consecutive urine samples documenting abstinence from METH.

But despite the state’s effort to target clinics with more diverse populations, 51 of the 67 patients in the pilot who completed a demographic survey — 76% — were White, according to the state BHDDH. The numbers of Black and Hispanic participants — 5 and 8 respectively — were too small, researchers said, to draw any conclusions about how well the technology worked for patients in those groups. Just over half of the patients in the pilot were “living in unstable housing,” which the BHDDH defined as either unsheltered or at risk of being homeless.

• CM interventions for meth addiction typically offer incentives for continued abstinence.
• Nationwide, the combination of cocaine and meth with fentanyl — a synthetic opioid 50 times more powerful than heroin — is driving what experts call the “fourth wave” of the opioid epidemic.
• “It’s easier to have a more optimistic perspective because we don’t have anything that works right now,” Jordan said.
• While that number might sound low, experts said the trial’s results are in the ballpark of the effectiveness of treatments for other types of addiction, like alcohol and tobacco.

Available statistical data indicates re-emergence of METH popularity and suggest an impending third epidemic of METH abuse. Alarmingly, there is no FDA-approved medication for METH use disorder (MUD). This disorder is currently treated with behavioral therapies; however, these therapies have limitations and would benefit from the addition of a MUD pharmacotherapy.

Patient Care Network

Unfortunately, clinical trials have not yet found consistently effective pharmacotherapy for MUD. This review outlines the history of METH use, provides information on current prevalence of METH abuse and MUD, describes medications that have been in clinical trials for MUD, and addresses current as meth addiction well as potential new treatments for MUD. The FDA-approved reSET mobile application, produced by Pear Therapeutics, contains a patient application and clinician dashboard and is designed to deliver CBT to people with MUD and other substance use disorders (with the exception of opioid use disorder).

• But nearly two decades after this historic legislation was passed, millions of Americans covered by Medicare continue to face unnecessary and discriminatory barriers to addiction care.
• In the world of addiction treatment, many specialists say meth is their most formidable challenge.
• Doctors can prescribe drugs already approved by the Food and Drug Administration for other purposes “off-label” to try to treat methamphetamine addiction.
• You may not feel alcohol’s effects as you typically would, so you might drink more alcohol than your body can process.
• “It’s progress and it’s quite significant,” says Dr. Nora Volkow, director of the National Institute on Drug Addiction, which funded the two-year clinical trial involving roughly 400 patients.
• When you take a drug, certain genetic factors can increase your risk of developing an addiction.Regular drug use changes your brain chemistry, affecting how you experience pleasure.

Faster approach for starting extended-release naltrexone to treat opioid use disorder shown effective

• “It’s almost like methamphetamines are falling from the sky right now, with the amount that’s coming through the border and on boats and planes,” says Matthew Donahue with the U.S.
• Ongoing meth use can lead to mild to severe withdrawal symptoms once you stop taking the drug.
• With this approach, patients receive rewards or incentives — usually in the form of cash or prizes — in exchange for abstinence.
• As a result, study participants were less likely to desire to use meth.

---